174 related articles for article (PubMed ID: 22113934)
1. An empirical phase diagram approach to investigate conformational stability of "second-generation" functional mutants of acidic fibroblast growth factor-1.
Alsenaidy MA; Wang T; Kim JH; Joshi SB; Lee J; Blaber M; Volkin DB; Middaugh CR
Protein Sci; 2012 Mar; 21(3):418-32. PubMed ID: 22113934
[TBL] [Abstract][Full Text] [Related]
2. Effects of solutes on empirical phase diagrams of human fibroblast growth factor 1.
Fan H; Li H; Zhang M; Middaugh CR
J Pharm Sci; 2007 Jun; 96(6):1490-503. PubMed ID: 17094138
[TBL] [Abstract][Full Text] [Related]
3. Sucralfate and soluble sucrose octasulfate bind and stabilize acidic fibroblast growth factor.
Volkin DB; Verticelli AM; Marfia KE; Burke CJ; Mach H; Middaugh CR
Biochim Biophys Acta; 1993 Nov; 1203(1):18-26. PubMed ID: 7692970
[TBL] [Abstract][Full Text] [Related]
4. Highly stable mutants of human fibroblast growth factor-1 exhibit prolonged biological action.
Zakrzewska M; Krowarsch D; Wiedlocha A; Olsnes S; Otlewski J
J Mol Biol; 2005 Sep; 352(4):860-75. PubMed ID: 16126225
[TBL] [Abstract][Full Text] [Related]
5. Formulation design and high-throughput excipient selection based on structural integrity and conformational stability of dilute and highly concentrated IgG1 monoclonal antibody solutions.
Bhambhani A; Kissmann JM; Joshi SB; Volkin DB; Kashi RS; Middaugh CR
J Pharm Sci; 2012 Mar; 101(3):1120-35. PubMed ID: 22147527
[TBL] [Abstract][Full Text] [Related]
6. The structure of human acidic fibroblast growth factor and its interaction with heparin.
Copeland RA; Ji H; Halfpenny AJ; Williams RW; Thompson KC; Herber WK; Thomas KA; Bruner MW; Ryan JA; Marquis-Omer D
Arch Biochem Biophys; 1991 Aug; 289(1):53-61. PubMed ID: 1716876
[TBL] [Abstract][Full Text] [Related]
7. Deamidation of polyanion-stabilized acidic fibroblast growth factor.
Volkin DB; Verticelli AM; Bruner MW; Marfia KE; Tsai PK; Sardana MK; Middaugh CR
J Pharm Sci; 1995 Jan; 84(1):7-11. PubMed ID: 7536241
[TBL] [Abstract][Full Text] [Related]
8. Effects of pH and polyanions on the thermal stability of fibroblast growth factor 20.
Fan H; Vitharana SN; Chen T; O'Keefe D; Middaugh CR
Mol Pharm; 2007; 4(2):232-40. PubMed ID: 17397238
[TBL] [Abstract][Full Text] [Related]
9. Engineering a Cysteine-Free Form of Human Fibroblast Growth Factor-1 for "Second Generation" Therapeutic Application.
Xia X; Kumru OS; Blaber SI; Middaugh CR; Li L; Ornitz DM; Sutherland MA; Tenorio CA; Blaber M
J Pharm Sci; 2016 Apr; 105(4):1444-53. PubMed ID: 27019961
[TBL] [Abstract][Full Text] [Related]
10. Destabilization, oligomerization and inhibition of the mitogenic activity of acidic fibroblast-growth factor by aurintricarboxylic acid.
Lozano RM; Rivas G; Giménez-Gallego G
Eur J Biochem; 1997 Aug; 248(1):30-6. PubMed ID: 9310356
[TBL] [Abstract][Full Text] [Related]
11. Probing the role of proline -135 on the structure, stability, and cell proliferation activity of human acidic fibroblast growth factor.
Davis JE; Alghanmi A; Gundampati RK; Jayanthi S; Fields E; Armstrong M; Weidling V; Shah V; Agrawal S; Koppolu BP; Zaharoff DA; Kumar TKS
Arch Biochem Biophys; 2018 Sep; 654():115-125. PubMed ID: 30031837
[TBL] [Abstract][Full Text] [Related]
12. Increased protein stability of FGF1 can compensate for its reduced affinity for heparin.
Zakrzewska M; Wiedlocha A; Szlachcic A; Krowarsch D; Otlewski J; Olsnes S
J Biol Chem; 2009 Sep; 284(37):25388-403. PubMed ID: 19574212
[TBL] [Abstract][Full Text] [Related]
13. Effect of low pH and heparin on the structure of acidic fibroblast growth factor.
Pineda-Lucena A; Núñez De Castro I; Lozano RM; Muñoz-Willery I; Zazo M; Giménez-Gallego G
Eur J Biochem; 1994 Jun; 222(2):425-31. PubMed ID: 7517355
[TBL] [Abstract][Full Text] [Related]
14. Thermodynamic characterization of mutants of human fibroblast growth factor 1 with an increased physiological half-life.
Culajay JF; Blaber SI; Khurana A; Blaber M
Biochemistry; 2000 Jun; 39(24):7153-8. PubMed ID: 10852713
[TBL] [Abstract][Full Text] [Related]
15. Physical stabilization of acidic fibroblast growth factor by polyanions.
Volkin DB; Tsai PK; Dabora JM; Gress JO; Burke CJ; Linhardt RJ; Middaugh CR
Arch Biochem Biophys; 1993 Jan; 300(1):30-41. PubMed ID: 7678726
[TBL] [Abstract][Full Text] [Related]
16. Mutagenesis of the nuclear localization sequence in EGF-1 alters protein stability but not mitogenic activity.
Friedman S; Zhan X; Maciag T
Biochem Biophys Res Commun; 1994 Feb; 198(3):1203-8. PubMed ID: 7509598
[TBL] [Abstract][Full Text] [Related]
17. Conversion of cysteine to serine residues alters the activity, stability, and heparin dependence of acidic fibroblast growth factor.
Ortega S; Schaeffer MT; Soderman D; DiSalvo J; Linemeyer DL; Gimenez-Gallego G; Thomas KA
J Biol Chem; 1991 Mar; 266(9):5842-6. PubMed ID: 1706340
[TBL] [Abstract][Full Text] [Related]
18. Formulation design of acidic fibroblast growth factor.
Tsai PK; Volkin DB; Dabora JM; Thompson KC; Bruner MW; Gress JO; Matuszewska B; Keogan M; Bondi JV; Middaugh CR
Pharm Res; 1993 May; 10(5):649-59. PubMed ID: 7686672
[TBL] [Abstract][Full Text] [Related]
19. Structure of a heparin-linked biologically active dimer of fibroblast growth factor.
DiGabriele AD; Lax I; Chen DI; Svahn CM; Jaye M; Schlessinger J; Hendrickson WA
Nature; 1998 Jun; 393(6687):812-7. PubMed ID: 9655399
[TBL] [Abstract][Full Text] [Related]
20. Biophysical and stabilization studies of the Chlamydia trachomatis mouse pneumonitis major outer membrane protein.
Cai S; He F; Samra HS; de la Maza LM; Bottazzi ME; Joshi SB; Middaugh CR
Mol Pharm; 2009; 6(5):1553-61. PubMed ID: 19650664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
